Remedium Bio
Latest round
- Series A
Last raised
- Aug 2026
Total raised
- $12M
Investors
- 9
About Remedium Bio
, operates as a gene therapy company that offers curative treatments for debilitating conditions. In August 2026, Remedium Bio Inc. The company offers various gene therapy solutions in the fields of rheumatology, endocrinology, neurology, and immunology. The company offers a broad range of bio-pipelines of therapies for immune and age-related conditions.
Who invested in Remedium Bio
9 investors across 2 rounds
See all investors in Remedium Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Remedium Bio
Who invested in Remedium Bio?
Remedium Bio has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Remedium Bio raised?
Remedium Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Remedium Bio last raise money?
Remedium Bio's most recent round on record is a Series A, in Aug 2026.
What does Remedium Bio do?
, operates as a gene therapy company that offers curative treatments for debilitating conditions.
Where is Remedium Bio headquartered?
Remedium Bio is headquartered in Boston, US.
Which VCs invest in companies like Remedium Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Remedium Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Remedium Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.